UBS’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$31.3M Buy
386,758
+58,681
+18% +$4.9M 0.02% 709
2014
Q2
$28.7M Buy
328,077
+40,350
+14% +$3.51M 0.02% 696
2014
Q1
$24.8M Buy
287,727
+27,947
+11% +$2.29M 0.02% 676
2013
Q4
$21M Buy
259,780
+83,242
+47% +$6.46M 0.02% 779
2013
Q3
$13.8M Buy
176,538
+47,879
+37% +$3.69M 0.01% 909
2013
Q2
$9.01M Buy
+128,659
New +$8.97M 0.01% 1116

Other funds holding EMN

UBS's EMN Position: Q3 2014 in Review

UBS increased its Eastman Chemical (EMN) stake by 18% in Q3 2014, buying an estimated $4.9M and bringing the position to 386,758 shares worth $31.3M. The position accounts for 0.02% of the portfolio, ranked #709.

UBS first reported a position in EMN in Q2 2013 and has held it in 6 quarters since. 533 funds tracked by Wall St. Rank hold EMN as of Q3 2014.

  • UBS held 386,758 shares of Eastman Chemical worth $31.3M as of Q3 2014.
  • UBS bought 58,681 Eastman Chemical shares in Q3 2014, an estimated $4.9M.
  • Eastman Chemical made up 0.02% of UBS's portfolio in Q3 2014, its #709 holding.
  • UBS first reported a position in Eastman Chemical in Q2 2013 and has held it in 6 quarters since.
  • 533 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.